577
Views
31
CrossRef citations to date
0
Altmetric
Clinical Focus: Pain Management - Review

Levorphanol use: past, present and future

, &
Pages 46-53 | Received 30 Nov 2015, Accepted 02 Dec 2015, Published online: 27 Dec 2015

References

  • Prommer E. Levorphanol: the forgotten opioid. Support Care Cancer. 2007;15(3):259–264.
  • McNulty JP. Can levorphanol be used like methadone for intractable refractory pain? J Palliat Med. 2007;10(2):293–296.
  • Levorphanol Prescribing Information. Solana Beach, CA: Sentynl Therapeutics, Inc.; 2015.
  • Stringer M, Makin MK, Miles J, et al. D-morphine, but not l-morphine has low micromolar affinity for the non-competitive NMDA site in rat forebrain. Neurosci Lett. 2000;295:21–24.
  • Codd E, Shank RP, Schupsky JJ, et al. Serotonin and norepinephrine uptake inhibiting activity of central acting analgesics. J Pharmacol Exp Ther. 1995;274:1263–1270.
  • Pham T, Fudin J, Raffa R. Is levorphanol a better opioid than methadone. Pain Med. 2015;16:1673–1679.
  • Atkinson TJ, Fudin J, Pandula A, et al. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther. 2013;35(11):1669–1689.
  • Zorn K, Fudin J. Treatment of neuropathic pain - the role of unique opioids. Pract Pain Manag. 2011;11(4):26–33.
  • Glazebrook A. Actions and uses of methorphinan. Br Med J. 1952;2:1328–1330.
  • Rowbotham R, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. New England J Med. 2003;348:1223–1232.
  • Prommer E. Levorphanol: revisiting an underutilized analgesic. Palliat Care. 2014;8:7–10.
  • Benson W, Stefko P, Randall L. Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers. J Pharmacol Exp Ther. 1953;109(2):189–200.
  • Logan B, Goldforel G, Hamilton R, et al. Five deaths resulting from abuse of dextromethorphan sold over the internet. J Anal Toxicol. 2009;33(2):99–103.
  • Smith HS, Peppin JF. Toward a systematic approach to opioid rotation. J Pain Res. 2014;7:589–608.
  • Clark J, Liu L, Price M, et al. Opiate receptor multiplicity: evidence for two U50,488-sensitive 1 subtypes and a novel 3 subtype. J Pharmacol Exp Ther. 1989;251:461–468.
  • Tive L, Ginsberg K, Pick CG, et al. Kappa3 receptors and levorphanol-induced analgesia. Neuropharmacology. 1992;31:851–856.
  • Zhang A, Xiong W, Bidlack JM, et al. 10-Ketomorphinan and 3-substituted-3-desoxymorphinam analogues as mixed  and µ opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors. J Med Chem. 2004;47:165–174.
  • Li JG, Zhang F, Jin XL, et al. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation. J Pharmacol Exp Ther. 2003;305(2):531–540.
  • Dixon R, Crews T, Inturrisi C, et al. Levorphanol: pharmacokinetics and steady state plasma concentrations in patients with pain. Res Commun Chem Pathol Pharmacol. 1983;41:3–17.
  • Coffman B, King CD, Rios GR, et al. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos. 1998;26:73–77.
  • Opioid Calculator. Conversion data and methods, in Practical Pain Management. 2012: Available from: http://opioidcalculator.practicalpainmanagement.com/methods.php Last accessed 11/1/2015
  • Hilal-Dandan R, Brunton L. Goodman and Gilman manual of pharmacology and therapeutics. New York: McGraw Hill Professional; 2013.
  • Moulin DE, Ling GSF, Pasternak GW. Unidirectional analgesic cross-tolerance between morphine and levorphanol in the rat. Pain. 1988;33:233–239.
  • Morrison J, Loan W, Dundee J. Controlled comparison of the efficacy of fourteen preparations in the relief of postoperative pain. Br Med J. 1971;3:287–290.
  • Banister EHDA. Six potent analgesic drugs-double blind in post-operative pain. Anaesthesia. 1974;29:158–162.
  • Hunt R, Foldes F. The use of levo-dromoran tartrate (levorphan tartrate) for relief of postoperative pain. New England J Med. 1953;248:803–807.
  • Gear R, Miaskowski C, Gordon NC, et al. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med. 1996;2(11):1249–1250.
  • Hysingla ER Prescribing Information. Stamford, CT: Purdue Pharma L.P; 2015.
  • BUTRANS - buprenorphine patch, extended release. Prescribing information. Stamford, CT: Purdue Pharma, L.P; 2014.
  • Krantz M, Kutinsky IB, Robertson AD, et al. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy. 2003;23(6):802–805.
  • Fanoe S, Jensen GB, Sjogren P, et al. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol. 2009;67(2):172–179.
  • Piguet V, Desmeules J, Ehret G, et al. QT interval prolongation in patients on methadone with concomitant drugs. J Clin Psychopharmacol. 2004;24(4):446–448.
  • Van Noord C, Eijgelsheim M, Stricker BH. Drug- and non-drug-associated QT interval prolongation. Br J Clin Pharmacol. 2010;70(1):16–23.
  • Center for Disease Control and Prevention. Vital signs: risk for overdose from methadone used for pain relief – United States, 1999-2010. Morbidity Mortality Weekly Rep. 2012;61(26):493–497.
  • Leal CP, Clivatti J, Garcia JBS, et al. Opioid-induced hyperalgesia (OIH). Braz J Anesthesiology. 2010;60(6):639–647.
  • Silverman S. Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician. 2009;12:679–684.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.